Climb Bio Inc. (CLYM) Income Statement Analysis - Revenue, Earnings & Profitability Metrics - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    Climb Bio Inc.

    NASDAQ: CLYM · Real-Time Price · USD
    2.42
    0.09 (3.86%)
    At close: Sep 05, 2025, 11:46 AM

    Climb Bio Income Statement

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
    Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
    Revenue
    		 n/a n/a n/a n/a
    Cost of Revenue
    		 n/a n/a n/a n/a
    Gross Profit
    		 n/a n/a n/a n/a
    Operating Income
    		 -82.02M -40.27M -45.13M -35.67M
    Interest Income
    		 8.13M 4.62M 1.38M n/a
    Pretax Income
    		 -73.9M -35.12M -45.24M -47.48M
    Net Income
    		 -73.9M -35.12M -45.24M -47.48M
    Selling & General & Admin
    		 16.02M 24.86M 18.92M 12.35M
    Research & Development
    		 14.34M 15.41M 26.21M 23.32M
    Other Expenses
    		 51.66M n/a n/a n/a
    Operating Expenses
    		 82.02M 40.27M 45.13M 35.67M
    Interest Expense
    		 n/a n/a n/a n/a
    Selling & Marketing Expenses
    		 n/a n/a n/a n/a
    Cost & Expenses
    		 82.02M 40.27M 45.13M 35.67M
    Income Tax Expense
    		 n/a n/a n/a n/a
    Shares Outstanding (Basic)
    		 48.16M 26.99M 26.31M 12.26M
    Shares Outstanding (Diluted)
    		 48.16M 26.99M 26.31M 12.26M
    EPS (Basic)
    		 -1.53 -1.3 -1.72 -4.24
    EPS (Diluted)
    		 -1.53 -1.3 -1.72 -4.24
    EBITDA
    		 -30.36M -40.27M -45.13M -35.67M
    EBIT
    		 -30.36M -40.27M -45.13M -35.67M
    Depreciation & Amortization
    		 n/a n/a n/a n/a

    Add to Watchlist